Treakisym bendamustine regulatory update

SymBio said Japan's Ministry of Health, Labor and Welfare approved an NDA for Treakisym bendamustine to treat refractory/relapsed low-grade non-Hodgkin's lymphoma (NHL) and mantle cell lymphoma (MCL)....